INTERNATIONAL PATENT: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, AMGEN INC. FILES APPLICATION FOR "INHALABLE MICROPARTICLES COMPRISING A PHOSPHOLIPID AND AN ANTIBODY OR ANTIBODY FRAGMENT"

GENEVA, July 3 -- THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (210 West 7th StreetAustin, TX 78701), AMGEN INC. (One Amgen Center DriveLaw Dept-Patent Operations, Mail Stop 28-5-AThousand Oaks, CA 91320-1799) filed a patent application (PCT/US2024/061355) for "INHALABLE MICROPARTICLES COMPRISING A PHOSPHOLIPID AND AN ANTIBODY OR ANTIBODY FRAGMENT" on Dec 20, 2024. With publication no. WO/2025/137495, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SMYTH, Hugh (107 Dean KeatonBME 3.510AAustin, TX 78712), NAIR, V...